To derive embryonic stem cells, it is necessary to remove critical cells from an embryo, resulting in its destruction. That triggers opposition from right-to-life critics of the research, who cite moral and ethical concerns.
A complicated legal fight over abortion pill mifepristone could reduce innovation in the biopharma industry, companies and experts in law and economics said.